Authors:
MILLER M
ZELLER K
KWITEROVICH PC
ALBERS JJ
FEULNER G
Citation: M. Miller et al., LECITHIN-CHOLESTEROL ACYLTRANSFERASE DEFICIENCY - IDENTIFICATION OF 2DEFECTIVE ALLELES IN FIBROBLAST CDNA, Journal of lipid research, 36(5), 1995, pp. 931-938
Authors:
MORIYAMA K
SASAKI J
ARAKAWA F
TAKAMI N
MAEDA E
MATSUNAGA A
TAKADA Y
MIDORIKAWA K
YANASE T
YOSHINO G
MARCOVINA SM
ALBERS JJ
ARAKAWA K
Citation: K. Moriyama et al., 2 NOVEL POINT MUTATIONS IN THE LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) GENE RESULTING IN LCAT DEFICIENCY - LCAT (G(873) DELETION) AND LCAT (GLY(344)-]SER), Journal of lipid research, 36(11), 1995, pp. 2329-2343
Citation: Se. Ravnik et al., STIMULATION OF HUMAN SPERM CAPACITATION BY PURIFIED LIPID TRANSFER PROTEIN, The Journal of experimental zoology, 272(1), 1995, pp. 78-83
Authors:
VAISMAN BL
KLEIN HG
ROUIS M
BERARD AM
KINDT MR
TALLEY GD
MEYN SM
HOYT RF
MARCOVINA SM
ALBERS JJ
HOEG JM
BREWER HB
SANTAMARINAFOJO S
Citation: Bl. Vaisman et al., OVEREXPRESSION OF HUMAN LECITHIN-CHOLESTEROL ACYLTRANSFERASE LEADS TOHYPERALPHALIPOPROTEINEMIA IN TRANSGENIC MICE, The Journal of biological chemistry, 270(20), 1995, pp. 12269-12275
Authors:
KLEIN HG
DUVERGER N
ALBERS JJ
MARCOVINA S
BREWER HB
SANTAMARINAFOJO S
Citation: Hg. Klein et al., IN-VITRO EXPRESSION OF STRUCTURAL DEFECTS IN THE LECITHIN-CHOLESTEROLACYLTRANSFERASE GENE, The Journal of biological chemistry, 270(16), 1995, pp. 9443-9447
Authors:
MARCOVINA SM
ALBERS JJ
GABEL B
KOSCHINSKY ML
GAUR VP
Citation: Sm. Marcovina et al., EFFECT OF THE NUMBER OF APOLIPOPROTEIN(A) KRINGLE-4 DOMAINS ON IMMUNOCHEMICAL MEASUREMENTS OF LIPOPROTEIN(A), Clinical chemistry, 41(2), 1995, pp. 246-255
Citation: Ay. Tu et al., FUNCTIONAL-CHARACTERIZATION OF THE PROMOTER REGION OF THE HUMAN PHOSPHOLIPID TRANSFER PROTEIN GENE, Biochemical and biophysical research communications, 217(3), 1995, pp. 705-711
Citation: Ay. Tu et al., ORGANIZATION OF HUMAN PHOSPHOLIPID TRANSFER PROTEIN GENE, Biochemical and biophysical research communications, 207(2), 1995, pp. 552-558
Authors:
ALBERS JJ
WOLFBAUER G
CHEUNG MC
DAY JR
CHING AFT
LOK S
TU AY
Citation: Jj. Albers et al., FUNCTIONAL EXPRESSION OF HUMAN AND MOUSE PLASMA PHOSPHOLIPID TRANSFERPROTEIN - EFFECT OF RECOMBINANT AND PLASMA PLTP ON HDL SUBSPECIES, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1258(1), 1995, pp. 27-34
Authors:
BROWN BG
STEWART BF
ZHAO XQ
HILLGER LA
POULIN D
ALBERS JJ
Citation: Bg. Brown et al., WHAT BENEFIT CAN BE DERIVED FROM TREATING NORMOCHOLESTEROLEMIC PATIENTS WITH CORONARY-ARTERY DISEASE, The American journal of cardiology, 76(9), 1995, pp. 93-97
Authors:
STEWART BF
BROWN BG
ZHAO XQ
HILLGER LA
SNIDERMAN AD
DOWDY A
FISHER LD
ALBERS JJ
Citation: Bf. Stewart et al., BENEFITS OF LIPID-LOWERING THERAPY IN MEN WITH ELEVATED APOLIPOPROTEIN-B ARE NOT CONFINED TO THOSE WITH VERY HIGH-LOW DENSITY LIPOPROTEIN CHOLESTEROL, Journal of the American College of Cardiology, 23(4), 1994, pp. 899-906
Authors:
MAHER VMG
BROWN BG
ZHAO XQ
CHEUNG M
MARCOVINA SM
ALBERS JJ
Citation: Vmg. Maher et al., CONTRASTING EFFECTS OF APOPROTEINS A-I AND A-II ON CORONARY-ARTERY DISEASE CHANGE IN MEN DURING 2.5 YEARS IN LIPID-LOWERING THERAPY, Journal of the American College of Cardiology, 1994, pp. 10000100-10000100
Authors:
MAHER VMG
BROWN BG
MACOVINA SM
SACCO D
LIN JT
HILLGER LA
ALBERS JJ
Citation: Vmg. Maher et al., THE ADVERSE EFFECT OF LIPOPROTEIN(A) ON CORONARY ATHEROSCLEROSIS AND CLINICAL EVENTS IS ELIMINATED BY SUBSTANTIALLY LOWERING LDL CHOLESTEROL, Journal of the American College of Cardiology, 1994, pp. 10000131-10000131
Authors:
DAY JR
ALBERS JJ
LOFTONDAY CE
GILBERT TL
CHING AFT
GRANT FJ
OHARA PJ
MARCOVINA SM
ADOLPHSON JL
Citation: Jr. Day et al., COMPLETE CDNA-ENCODING HUMAN PHOSPHOLIPID TRANSFER PROTEIN FROM HUMANENDOTHELIAL COILS, The Journal of biological chemistry, 269(12), 1994, pp. 9388-9391
Citation: Sm. Marcovina et al., BIOLOGICAL VARIABILITY OF CHOLESTEROL, TRIGLYCERIDE, LOW-DENSITY AND HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL, LIPOPROTEIN(A), AND APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B, Clinical chemistry, 40(4), 1994, pp. 574-578
Authors:
MARCOVINA SM
ALBERS JJ
KENNEDY H
MEI JV
HENDERSON LO
HANNON WH
Citation: Sm. Marcovina et al., INTERNATIONAL FEDERATION OF CLINICAL-CHEMISTRY STANDARDIZATION PROJECT FOR MEASUREMENTS OF APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B .4. COMPARABILITY OF APOLIPOPROTEIN-B VALUES BY USE OF INTERNATIONAL REFERENCEMATERIAL, Clinical chemistry, 40(4), 1994, pp. 586-592
Authors:
BACHORIK PS
LOVEJOY KL
CARROLL MD
JOHNSON CL
ALBERS JJ
MARCOVINA SM
Citation: Ps. Bachorik et al., MEASUREMENT OF APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B DURING THE NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES)-III, Clinical chemistry, 40(10), 1994, pp. 1915-1920
Authors:
DAY JR
ALBERS JJ
GILBERT TL
WHITMORE TE
MCCONATHY WJ
WOLFBAUER G
Citation: Jr. Day et al., PURIFICATION AND MOLECULAR-CLONING OF HUMAN APOLIPOPROTEIN F+, Biochemical and biophysical research communications, 203(2), 1994, pp. 1146-1151
Citation: Ca. Marzetta et al., LIPID TRANSFER PROTEIN-MEDIATED DISTRIBUTION OF HDL-DERIVED CHOLESTERYL ESTERS AMONG PLASMA APO-B-CONTAINING LIPOPROTEIN SUBPOPULATIONS, Arteriosclerosis and thrombosis, 13(6), 1993, pp. 834-841
Authors:
JARVIK GP
WIJSMAN E
LITTLE RE
ALBERS JJ
MOTULSKY AG
BRUNZELL JD
Citation: Gp. Jarvik et al., HOST AND ENVIRONMENTAL-EFFECTS ON PLASMA APOLIPOPROTEIN-B, International journal of clinical & laboratory research, 23(4), 1993, pp. 215-220
Citation: Bg. Brown et al., PLAQUE REGRESSION, PLAQUE DISRUPTION AND CLINICAL EVENTS - A RATIONALE FOR LIPID-LOWERING IN CORONARY-ARTERY DISEASE, Canadian journal of cardiology, 9, 1993, pp. 21-29
Authors:
KLEIN HG
SANTAMARINAFOJO S
DUVERGER N
CLERC M
DUMON MF
ALBERS JJ
MARCOVINA S
BREWER HB
Citation: Hg. Klein et al., FISH EYE SYNDROME - A MOLECULAR DEFECT IN THE LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) GENE ASSOCIATED WITH NORMAL ALPHA-LCAT-SPECIFIC ACTIVITY - IMPLICATIONS FOR CLASSIFICATION AND PROGNOSIS, The Journal of clinical investigation, 92(1), 1993, pp. 479-485
Authors:
MARCOVINA SM
ALBERS JJ
HENDERSON LO
HANNON WH
Citation: Sm. Marcovina et al., INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY STANDARDIZATION PROJECT FOR MEASUREMENTS OF APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B .3. COMPARABILITY OF APOLIPOPROTEIN-A-I VALUES BY USE OF INTERNATIONAL REFERENCE MATERIAL, Clinical chemistry, 39(5), 1993, pp. 773-781
Authors:
ZHAO XQ
BROWN BG
HILLGER L
SACCO D
BISSON B
FISHER L
ALBERS JJ
Citation: Xq. Zhao et al., EFFECTS OF INTENSIVE LIPID-LOWERING THERAPY ON THE CORONARY-ARTERIES OF ASYMPTOMATIC SUBJECTS WITH ELEVATED APOLIPOPROTEIN-B, Circulation, 88(6), 1993, pp. 2744-2753